Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Olle Hernell is active.

Publication


Featured researches published by Olle Hernell.


Journal of Pediatric Gastroenterology and Nutrition | 1995

Human Milk K-casein and Inhibition of Helicobacter pylori Adhesion to Human Gastric Mucosa

Mats Strömqvist; P. Falk; S. Bergström; Lennart Hansson; Bo Lönnerdal; S. Normark; Olle Hernell

Summary: Readily digested caseins, which account for almost half of the protein content in human milk, are important as nutritional protein for breast-fed infants. It has also been advocated that part of the antimicrobial activity of human milk resides in the caseins, most likely the glycosylated K-casein. To explore this possibility, we purified K-casein from human milk to homogeneity by a two-step size-exclusion chromatography procedure. Purified human K-casein, in contrast to K-casein purified from bovine milk, effectively inhibited the cell lineage-specific adhesion of fluoroisothiocyanate-labeled Helicobacter pylori to human gastric surface mucous cells. The inhibitory activity was abolished by metaperiodate oxidation and considerably reduced by preincubation with α-L- fucosidase but not with α-N-acetylneuraminidase or endo-β-galactosidase. These results strongly support the view that fucose containing carbohydrate moieties of human K-casein are important for inhibition of H. pylori adhesion and, thus, infection. They also suggest that breastfeeding may protect from infection by H. pylori during early life and that species-specific glycosylation patterns, as illustrated by human and bovine K-casein, partly determine both the narrow host spectrum of this human gastric pathogen and the capacity to resist infection.


European Journal of Clinical Nutrition | 2003

Total energy expenditure and physical activity level in healthy young Swedish children 9 or 14 months of age

Catharina Tennefors; Wa Coward; Olle Hernell; A Wright; Elisabet Forsum

Objectives: To measure total energy expenditure (TEE) and total body water (TBW) in healthy Swedish children 9 or 14 months of age. To compare their TEE with current recommendations for energy intake. To define their body composition and relate this to energy expenditure.Design: Children were investigated at 9 or 14 months. The following variables were measured: TEE and TBW (by the doubly labelled water method), weight and length. Total body fat (TBF), sleeping metabolic rate, activity energy expenditure and physical activity level (PAL) were calculated.Subjects: Thirty infants 9 months of age and 29 children 14 months of age.Results: TEE was 323±38, 322±29, 313±23 and 331±28 kJ/kg/day in 9-month-old girls, 9-month-old boys, 14-month-old girls and 14-month-old boys, respectively. At 9 months of age girls and boys contained 29.6±4.8 and 29.7±4.5% TBF, respectively. At 14 months the corresponding figures were 29.1±4.3 and 28.2±4.3%. There was a significant negative relationship between PAL and %TBF (r=−0.81, P<0.001, n=59).Conclusions: Measured TEE plus calculated energy cost of growth confirm previous estimates that the physiological energy requirements of children 9 and 14 months of age are 15–20% lower than current recommendations for energy intake. One possible interpretation of the relationship between PAL and %TBF is that children with a high TBF content are less physically active than children with less TBF. However, this relationship needs further studies.


Archive | 1994

Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals

Lars Bläckberg; Michael Edlund; Lennart Hansson; Olle Hernell; Lennart G. Lundberg; Mats Strömqvist; Jan Törnell


Archive | 1993

Dna encoding kappa-casein, process for obtaining the protein and use thereof

Lennart Hansson; Mats Strömqvist; Sven Bergström; Olle Hernell; Jan Törnell


Archive | 1991

Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them

Gunnar Bjursell; Lars Bläckberg; Peter Carlsson; Sven Enerbäck; Olle Hernell; Jeanette Nilsson; Thomas Olivecrona


Archive | 2013

A nutritional composition

Bo Lönnerdal; Olle Hernell; Lars-Börje Sjöberg; Catharina Tennefors


Archive | 1992

Gene encoding a human beta-casein process for obtaining the protein and use thereof in an infant formula

Sven Bergström; Olle Hernell; Bo Lönnerdal; Karin Hjalmarsson; Lennart Hansson; Jan Törnell; Mats Strömqvist


Official Gazette of the United States Patent and Trademark Office Patents | 1998

Transgenic non-human mammals producing BSSL variants

Lars Bläckberg; Michael Edlund; Stig Hansson; Olle Hernell; Lennart Lundberg; Mats Strömqvist; Jan Törnell


Archive | 2014

NEW PROPHYLACTIC USE FOR PREVENTION OF INFECTIONS

Bo Lönnerdal; Olle Hernell; Lars-Börje Sjöberg; Catharina Tennefors


Archive | 2013

METHODS FOR TREATMENT OF INFLAMMATORY DISEASES

Olle Hernell; Susanne Lindquist; Lennart G. Lundberg

Collaboration


Dive into the Olle Hernell's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bo Lönnerdal

Memorial University of Newfoundland

View shared research outputs
Top Co-Authors

Avatar

Lennart G. Lundberg

Chalmers University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael J. Lentze

Boston Children's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge